NO982105L - Nye mellomprodukter og deres anvendelse for fremstilling av N,N'-broslÕtte bisindolylmaleimider - Google Patents

Nye mellomprodukter og deres anvendelse for fremstilling av N,N'-broslÕtte bisindolylmaleimider

Info

Publication number
NO982105L
NO982105L NO982105A NO982105A NO982105L NO 982105 L NO982105 L NO 982105L NO 982105 A NO982105 A NO 982105A NO 982105 A NO982105 A NO 982105A NO 982105 L NO982105 L NO 982105L
Authority
NO
Norway
Prior art keywords
preparation
new intermediates
bridged bisindolylmaleimides
bisindolylmaleimides
bridged
Prior art date
Application number
NO982105A
Other languages
English (en)
Other versions
NO310195B1 (no
NO982105D0 (no
Inventor
Margaret M Faul
Christine A Krumrich
Jr Leonard L Winneroski
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=21725638&utm_source=***_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO982105(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of NO982105L publication Critical patent/NO982105L/no
Publication of NO982105D0 publication Critical patent/NO982105D0/no
Publication of NO310195B1 publication Critical patent/NO310195B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/08—Bridged systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/22—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains four or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Diabetes (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hematology (AREA)
  • Cardiology (AREA)
  • Obesity (AREA)
  • Psychiatry (AREA)
  • Rheumatology (AREA)
  • Emergency Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Hospice & Palliative Care (AREA)
  • Vascular Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Endocrinology (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyrrole Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
NO19982105A 1995-11-20 1998-05-08 Nye mellomprodukter og deres anvendelse for fremstilling av N,N'-broslåtte bisindolylmaleimider NO310195B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US734595P 1995-11-20 1995-11-20
PCT/US1996/018518 WO1997019080A1 (en) 1995-11-20 1996-11-18 Novel intermediates and their use to prepare n,n'-bridged bisindolylmaleimides

Publications (3)

Publication Number Publication Date
NO982105L true NO982105L (no) 1998-05-08
NO982105D0 NO982105D0 (no) 1998-05-08
NO310195B1 NO310195B1 (no) 2001-06-05

Family

ID=21725638

Family Applications (1)

Application Number Title Priority Date Filing Date
NO19982105A NO310195B1 (no) 1995-11-20 1998-05-08 Nye mellomprodukter og deres anvendelse for fremstilling av N,N'-broslåtte bisindolylmaleimider

Country Status (31)

Country Link
EP (1) EP0776899B1 (no)
JP (2) JP4100708B2 (no)
KR (1) KR100342142B1 (no)
CN (1) CN1066734C (no)
AR (2) AR004719A1 (no)
AT (1) ATE191219T1 (no)
AU (1) AU701659B2 (no)
BR (1) BR9611709A (no)
CA (1) CA2237401C (no)
CO (1) CO4750824A1 (no)
CZ (1) CZ150398A3 (no)
DE (1) DE69607443T2 (no)
DK (1) DK0776899T3 (no)
EA (1) EA000639B1 (no)
ES (1) ES2145978T3 (no)
GR (1) GR3033729T3 (no)
HU (1) HU225716B1 (no)
IL (1) IL124415A (no)
MX (1) MX9803791A (no)
MY (1) MY118946A (no)
NO (1) NO310195B1 (no)
NZ (1) NZ323282A (no)
PE (1) PE17998A1 (no)
PL (1) PL184728B1 (no)
PT (1) PT776899E (no)
TR (1) TR199800876T2 (no)
TW (1) TW371661B (no)
UA (1) UA56145C2 (no)
WO (1) WO1997019080A1 (no)
YU (1) YU49316B (no)
ZA (1) ZA969645B (no)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU758241B2 (en) * 1998-03-13 2003-03-20 University Of British Columbia, The Granulatimide derivatives for use in cancer treatment
CA2245029A1 (en) 1998-03-13 1999-09-13 University Of British Columbia Granulatimide compounds as g2 checkpoint inhibitors
US6127401A (en) * 1998-06-05 2000-10-03 Cephalon, Inc. Bridged indenopyrrolocarbazoles
US6300106B1 (en) 2000-11-22 2001-10-09 Ppg Industries Ohio, Inc. Method of preparing 3-[2-{(Methylsulfonyl)oxy}-ethoxy ]-4-(triphenylmethoxy)-1-butanol, methane sulfonate
EP2181999A1 (en) 2008-11-03 2010-05-05 Zentiva, A.S. Method of manufacturing ruboxistarin
WO2023192984A1 (en) * 2022-03-31 2023-10-05 4M Therapeutics Inc. N-desmethyl ruboxistaurin as kinase inhibitor

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL94274A0 (en) * 1989-05-05 1991-03-10 Goedecke Ag Maleinimide derivatives,process for the preparation thereof and pharmaceutical compositions containing the same
US5380746A (en) * 1989-05-05 1995-01-10 Goedecke Aktiengesellschaft Bis-(1H-indol-3-YL)-maleinimide derivatives, processes for the preparation thereof and pharmaceutical compositions containing them
AU687909B2 (en) * 1993-12-07 1998-03-05 Eli Lilly And Company Protein kinase C inhibitors
US5624949A (en) * 1993-12-07 1997-04-29 Eli Lilly And Company Protein kinase C inhibitors
US5559228A (en) * 1995-03-30 1996-09-24 Eli Lilly And Company Synthesis of bisindolylmaleimides

Also Published As

Publication number Publication date
YU49316B (sh) 2005-06-10
KR100342142B1 (ko) 2002-08-22
NZ323282A (en) 1999-01-28
JP4100708B2 (ja) 2008-06-11
IL124415A0 (en) 1998-12-06
EA199800368A1 (ru) 1998-12-24
DK0776899T3 (da) 2000-07-10
PE17998A1 (es) 1998-04-20
PT776899E (pt) 2000-08-31
YU61096A (sh) 1999-03-04
JP2000500496A (ja) 2000-01-18
HUP9901975A3 (en) 2000-01-28
IL124415A (en) 2003-11-23
DE69607443D1 (de) 2000-05-04
HUP9901975A2 (hu) 1999-11-29
WO1997019080A1 (en) 1997-05-29
ES2145978T3 (es) 2000-07-16
AR004719A1 (es) 1999-03-10
NO310195B1 (no) 2001-06-05
MY118946A (en) 2005-02-28
AR004718A1 (es) 1999-03-10
NO982105D0 (no) 1998-05-08
CA2237401C (en) 2003-10-21
CZ150398A3 (cs) 1998-12-16
BR9611709A (pt) 1999-02-23
KR19990067600A (ko) 1999-08-25
AU7738896A (en) 1997-06-11
TR199800876T2 (xx) 1998-08-21
EP0776899B1 (en) 2000-03-29
ZA969645B (en) 1998-05-18
UA56145C2 (uk) 2003-05-15
CN1207740A (zh) 1999-02-10
HU225716B1 (en) 2007-07-30
CO4750824A1 (es) 1999-03-31
PL184728B1 (pl) 2002-12-31
DE69607443T2 (de) 2000-08-10
PL326753A1 (en) 1998-10-26
CN1066734C (zh) 2001-06-06
CA2237401A1 (en) 1997-05-29
JP2008138006A (ja) 2008-06-19
TW371661B (en) 1999-10-11
EA000639B1 (ru) 1999-12-29
GR3033729T3 (en) 2000-10-31
AU701659B2 (en) 1999-02-04
ATE191219T1 (de) 2000-04-15
EP0776899A1 (en) 1997-06-04
MX9803791A (es) 1998-09-30

Similar Documents

Publication Publication Date Title
NO305833B1 (no) Naftylforbindelser, mellomprodukter og anvendelse av forbindelsene
NO980720D0 (no) Pyridazin-3-on-derivater, deres anvendelse og mellomprodukter for deres fremstilling
NO975710D0 (no) Nye Dolastatinderivater, deres fremstilling og anvendelse
NO307513B1 (no) 2,8-disubstituert chinazolinon og anvendelse derav
NO961006D0 (no) Fosfonomononukleinsyrer, fremgangsmåter for fremstilling derav og anvendelse av forbindelsene
NO982802D0 (no) Nye 5-amino-3-cyano-4-etylsulfinyl-1-fenyl-pyrazol-forbindelser og deres anvendelse som pesticider
DK0817779T3 (da) Nye taxoider, deres fremstilling og farmaceutiske præparater deraf
DK0876362T3 (da) Nye taxoider, deres fremstilling og farmaceutiske præparater deraf
KR970001343A (ko) 나프탈렌 유도체,그의 제조 방법,및그의 중간체
IS4781A (is) Laktón afleiður af 17.beta.-karboxý, karbóþíó og amíð andróstan afleiður
NO894539L (no) Fremgangsmaate for fremstilling av nye 2'-halomethyliden-,2'-ethenyliden- og 2'-ethynylcytidin-, uriden og guanosinderivater.
FI956298A0 (fi) 3-fenyyli-isokinolin-1(2H)-oneja, niiden valmistus ja terapeuttinen käyttö
NO953673D0 (no) [1,2,4ÅTriazolo[4,3-aÅkinoksalinderivater, deres fremstilling og anvendelse
NO962477L (no) Benzamidderivater, deres fremstilling og deres terapautiske anvendelse
NO900643L (no) Fremgangsmaate for fremstilling og anvendelse av 2,3,23-trihydroksi-urs-12-ener og deres derivater.
NO982105D0 (no) Nye mellomprodukter og deres anvendelse for fremstilling av N,N'-broslÕtte bisindolylmaleimider
NO971424D0 (no) Nye heterocyklisk substituerte imidazolo-kinoksalidoner, deres fremstilling og anvendelse
NO973230D0 (no) Nye peptider, deres fremstilling og anvendelse
NO991622D0 (no) Nye derivater av pentaerytritt, deres fremstilling og anvendelse sÕvel som mellomprodukt for syntese av det samme
DE69611303T2 (de) Benzolsulfonamidderivate, ihre herstellung und ihre therapeutische verwendung
NO921086D0 (no) Fremgangsmaate for fremstilling og anvendelse av substituerte 2',3'-didesoksy-5-trifluormetyluridiner
DK0869952T3 (da) Derivater af 5-naphthalen-1-yl-1,3-dioxaner, fremstilling og terapeutisk anvendelse heraf
NO970428D0 (no) Fremgangsmåte for fremstilling av antimikrobielle kinolonyllaktamforbindelser og nye mellomprodukter
NO306402B1 (no) 3-arylalkenyl-1,2,4-oksadiazolderivater og deres anvendelse, samt mellomprodukter for oppnaaelse av derivatene
IT1252659B (it) Procedimento per la depurazione dell'1,1,1-trifluoro-2-fluoroetano e dell'1,1,1-trifluoro-2,2-dicloroetano

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees